Target intelligence / Profile preview

Carbamoyl phosphate synthetase 1 (CPS1)

Target
CPS1
Molecular classification
Enzyme, Mitochondrial enzyme, Ligase
01

Overview

Carbamoyl phosphate synthetase 1 (*CPS1*) is a mitochondrial enzyme encoded by the *CPS1* gene located on chromosome 2q34. CPS1 catalyzes the first, rate-limiting step of the urea cycle by combining ammonia and bicarbonate to form carbamoyl phosphate, which is essential for detoxification of ammonia in the liver. Its mRNA is mainly expressed in hepatocytes. Mutations or repression of *CPS1* lead to hyperammonemia, resulting in severe neurological damage or death. It is of interest both as a biomarker of liver function and as a potential RNA-level target for intervention in certain liver cancers and metabolic disorders[1][3][4][6][7][9].

Other names
CPSICPS 1Carbamoyl-phosphate synthase 1Carbamoyl phosphate synthase 1
02

Mechanism of action

For ammonia-scavenging: Compounds induce CPS1 expression to enhance ammonia elimination\nFor experimental silencing: RNAi/antisense to reduce CPS1 mRNA for research in cancer cell lines

03

Biological functions

Urea cycleAmmonia detoxificationNitrogen metabolismRegulation of liver function
04

Disease associations

Urea cycle disorders (hyperammonemia)Liver injuryCancer (notably downregulated in hepatocellular carcinoma)Neurological dysfunction via ammonia accumulationCirculatory complications in specific contexts
05

Safety considerations

Deficiency leads to life-threatening hyperammonemia and CNS toxicity (seizures, coma)Loss-of-function is incompatible with survival without interventionPromoter or epigenetic silencing may facilitate cancer progression
06

Interacting drugs

Sodium phenylbutyrate

1 more in the full profile.

07

Biomarkers

CPS1 protein/mRNA for acute liver injury biomarkerCPS1 mRNA levels as marker for urea cycle integrity and hepatic functionCo-upregulation in cancer (intrahepatic cholangiocarcinoma) correlates with prognosis

Beyond the preview

Go deeper on Carbamoyl phosphate synthetase 1 (CPS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Carbamoyl phosphate synthetase 1 (CPS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call